Sentences with phrase «many other cancer patients»

She spoke at Genentech, a cancer research firm, exchanged e-mails with half a dozen other cancer patients nationwide and was interviewed on NPR as a voice of nonsmoker lung - cancer sufferers.

«I hope this debate will give hope to other cancer patients like me.

We suspect this strategy could benefit other cancer patient populations.»

«We will then use this technique to explore prostate tissues from other cancer patients.

Hanshaw says she didn't experience too many of the life - altering side effects that other cancer patients might experience from chemotherapy or radiation, but she did have dry lips.

As a side note, if your surgeon wants to «debulk» your colon and / or stomach of cancer cells and tumors, keep this in mind: colon cancer and stomach cancer patients have a lower cure rate than other cancer patients precisely because surgery and chemotherapy damages the ability of their stomach and colon to properly digest foods.

If your surgeon wants to «debulk» your colon and / or stomach of cancer cells and tumors, keep this in mind: Colon cancer and stomach cancer patients have a lower cure rate than other cancer patients precisely because surgery and chemotherapy damage the ability of their stomach and colon to properly digest foods.

The researchers did not give the supplements to 24 other cancer patients also in the study.

Despite the extremely personal nature of the work, Melissa hopes these paintings speak to others facing a similar battle: «I want these images to show other cancer patients, locked to an IV pump, that they are not alone in their struggle for survival.»

Miami About Blog Jessica Lynne a Stage 4 Hodgkin's Lymphoma Cancer Fighter started this blog to help raise awareness, document her journey, and help other cancer patients in the process.

Not exact matches

PICI (pronounced «pie - sea»), as it's called by its member scientists, is doing something unprecedented in academic medicine: combining and coordinating the efforts of six of the top cancer immunology centers in the country — MD Anderson Cancer Center, Memorial Sloan Kettering, Penn Medicine, Stanford, UCLA, and UCSF — in order to greatly expand and, more important, to accelerate our understanding of why some immune - based treatments work miraculously in some patients and not at all in ocancer immunology centers in the country — MD Anderson Cancer Center, Memorial Sloan Kettering, Penn Medicine, Stanford, UCLA, and UCSF — in order to greatly expand and, more important, to accelerate our understanding of why some immune - based treatments work miraculously in some patients and not at all in oCancer Center, Memorial Sloan Kettering, Penn Medicine, Stanford, UCLA, and UCSF — in order to greatly expand and, more important, to accelerate our understanding of why some immune - based treatments work miraculously in some patients and not at all in others.

In the most recent of these reports (in the latest issue of Science), Dr. Jennifer Wargo, a surgeon and research scientist at M.D. Anderson, along with several dozen colleagues at other institutions, reveal that the composition of a patient's gut microbiota can significantly influence whether he or she responds to an immune checkpoint inhibitor — the type of cancer immunotherapy that releases the emergency brakes in the car analogy above.

Shkreli originally became infamous for his other former company Turing Pharma's 5,000 % price hike for a drug used by cancer and AIDS patients.

Patients who exercised more than others had a lower readmission risks following cancer surgery.

One setback for these therapies which use the body's immune system to fight cancers is that they are, at times, more effective in certain patient pools than others.

Other studies, meanwhile, are examining tryp's potential efficacy as an antifungal agent; and as a prognostic indicator in patients with brain cancer (as seen by increased uptake of the amino acid on a PET scan).

«While we are disappointed CheckMate - 026 did not meet its primary endpoint in this broad patient population, we remain committed to improving patient outcomes through our comprehensive development program, including the ongoing Phase III CheckMate - 227 study exploring the potential of the combination of Opdivo plus [our other cancer immunotherapy] Yervoy for PD - L1 positive patients, and Opdivo plus Yervoy, or Opdivo plus chemotherapy in PD - L1 negative patients,» he added.

In it, she talks about her true passion — doing something good for other people, which explains why Student Maid cleans free for cancer patients.

Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.

When Jedd Wolchok, a cancer doctor and immunologist leading a Yervoy trial at Memorial Sloan Kettering, examined a melanoma patient's scan 12 weeks after he'd received his course of treatment, the results were utterly disappointing — just like those of any other metastatic patient in the final throes of the disease: The tumors had gotten bigger, and there were more of them.

MEG TIRRELL, NIGHTLY BUSINESS REPORT CORRESPONDENT: Since they were approved in 2014, drugs that stimulate the immune system have been giving new hope to patients with melanoma, kidney cancer, lymphoma and other cancers, including famously to President Jimmy Carter, who credited the drug called Keytruda with shrinking tumors that had spread to his brain.

At other points in the hour - long program, Ryan discussed Republican plans for repealing and replacing President Obama's health - care law with a cancer patient who credits the law with saving his life.

This surgeon was one of the best in this field and had even successfully tried a treatment on this exact cancer for other patients that tripled the five - year - survival odds — from 5 percent to 15 percent — albeit with a poor quality of life.

Maastricht, The Netherlands, 1 November 2017 — Cristal Therapeutics, a clinical stage biopharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, announced today that it has begun a Phase 1b...

For some it may be the homeless, divorced moms, cancer patients, etc and for others it may be gay marriage.

I tell you that if within one day everyone in the world woke up to all cancer patients completely and permanently cured, all amputees with their limbs restored, all sëx traffickers turned loose their victims, all child abuse stopped and captives turned loose, everybody laid down their weapons and shook hands, and all down syndrome and other people with genetic maladies were cured; all this taken together, would definitely get the entire worlds attention, would it not?

Because I cook for others (I teach «healthy eating» to cancer patients) I often have lots of leftover bits and bobs.

I can't imagine how good it must feel to receive some of those emails from cancer patients or others who are sustained by his product.

A breast cancer advocate honors his mother and other breast cancer patients by sharing the story that set him on an unexpected mission of support.

Advocacy A breast cancer advocate honors his mother and other breast cancer patients by sharing the story that set him on an unexpected mission of support.

There are other ways to comfort breast cancer patients and their families.

While other measures lacked the same urgency or drama as mayoral control, which did not get done this session, lawmakers did approve scores of bills in recent days, like a provision that would make it easier for cancer patients to sue for malpractice, and a ban on e-cigarettes in bars and restaurants.

In New York, Cuomo signed the Compassionate Care Act in July 2014, which legalized medical marijuana for patients who are certified by medical practitioners as having «serious» conditions, including cancer, AIDS, severe chronic pain, severe nausea, and other ailments.

The Bill - which was passed by the House of Lords - would have allowed doctors to test cutting edge new treatments on patients to help find cures for cancer and other serious illnesses.

A bill that would allow more patients with cancer, HIV and other serious maladies to sue for medical malpractice has been overwhelmingly approved by the state Assembly, but it stands a dwindling chance of even getting a floor debate in the Senate.

Cuomo, who had previously opposed legalizing medical marijuana, will announce an executive action in his State of the State address Wednesday that will permit just 20 hospitals to prescribe pot for patients with cancer, glaucoma or other serious diseases or conditions, according to the New York Times.

In an accompanying briefing book, the Cuomo administration described who would be eligible: patients with cancer, glaucoma and other specific diseases listed by the Health Department and «who are in a life - threatening or sense - threatening situation.»

Patients were put at risk of cancer and other serious harm because of a botched # 330 million NHS outsourcing deal, the spending watchdog has found.Patients were put at risk of cancer and other serious harm because of a botched # 330 million NHS outsourcing deal, the spending watchdog has found.Patients were put at risk of cancer and other serious harm because of a botched # 330 million NHS outsourcing deal, the spending watchdog has found.

ALBANY — A bill that would allow more patients with cancer, HIV and other serious maladies to sue for medical malpractice has been overwhelmingly approved by the state Assembly, but it stands a dwindling chance of even getting a floor debate in the Senate.

«We feel it'll be able to help kill cancer cells in 80 percent of breast cancer patients,» said Dr. Olson, who added that their antibody has the potential to help kill lung, colon, prostate and other cancer cells, too.

Critics say an oils - only approach would provide relief for some kids suffering from seizures, but would be of little benefit to cancer and other patients with chronic pain who use marijuana for immediate relief.

Mr. Cuomo said he will use an executive order to revive the Antonio G. Olivieri controlled substances therapeutic research program, which was established by law in 1980 and discontinued soon after, and allow up to 20 hospitals to dispense marijuana to approved patients suffering from cancer and other serious illnesses.

Dr. Marcus E. Martinez, who runs a family medical practice in Hoosick Falls, told the Times Union last year that he and his father, who opened the practice in 1956, have noted rare and aggressive forms of cancer in patients, as well as thyroid disease and other health problems.

Prosecutors alleged that the legislator had «funneled half a million dollars of taxpayer money and other official benefits» to the doctor for his cancer research, and that Dr. Taub in turn steered patients with asbestos - related legal claims to the law firm, which shared its fees with Mr. Silver.

And using cells from someone other than the cancer patient being treated might trigger an immune response against the foreign cells.

Associate professor Mary - Ellen Taplin, of the Dana - Farber Cancer Institute, Boston, USA, will tell the 26th EORTC - NCI - AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, that galeterone was well tolerated by patients in the ARMOR2 trial, and also lowered PSA levels in a subset of men with CRPC that was resistant to other drugs that target the cancer, such as enzalutamide and abiratCancer Institute, Boston, USA, will tell the 26th EORTC - NCI - AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, that galeterone was well tolerated by patients in the ARMOR2 trial, and also lowered PSA levels in a subset of men with CRPC that was resistant to other drugs that target the cancer, such as enzalutamide and abiratCancer Therapeutics in Barcelona, Spain, that galeterone was well tolerated by patients in the ARMOR2 trial, and also lowered PSA levels in a subset of men with CRPC that was resistant to other drugs that target the cancer, such as enzalutamide and abiratcancer, such as enzalutamide and abiraterone.

Now, Emily has remained cancer - free for almost five years and her parents have created a foundation to help other patients access experimental cancer therapies.

As researchers learn more about genetic profile of various cancers, other work is charging ahead to deliver personalized vaccines targeted to a patient's own tumor cells

That study showed how a similar model can be used to understand immune response in patients with pancreatic cancer who survive longer than others.

On May 23, the Food and Drug Administration approved pembrolizumab for cancer patients with mismatch repair mutations for whom other drugs have failed.